AMS focuses on highly active substances and challenging APIs with a potency up to OEL ≤ 1µg/m3 as well as low solubility or low dose drugs with immediate and controlled-release properties. Innovative formulation science and manufacturing technologies are utilized together with advanced formulation knowledge and excellent particle engineering capabilities.
Most importantly, AMS believes in a science-based approach to drug product development and manufacturing. We combine knowledge from the pharmaceutical sciences, nano-technology, drug delivery and engineering to effectively develop and manufacture advanced drug products. AMS believes that empirical approaches in development and manufacturing can increase the risk of process or product failure. Thus, we combine our background in the life sciences and in process engineering to offer the best development and manufacturing concepts to our clients.
In order to reflect this multidisciplinary approach AMS employees hold advanced degrees from a variety of different schools and disciplines.